Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.
Labeling: Incorrect or Missing Lot and/or Exp Date
CareFusion 303 recalled Alaris Pump Infusion Sets on September 11, 2025, after identifying performance issues. The recall affects multiple model numbers due to potential inaccuracies in flow rate and alarm settings. Healthcare providers must stop using these devices immediately and follow recall instructions.
Infusion pump module used with compatible pump infusion sets may perform outside the established performance ranges for flow rate and bolus accuracy, downstream and upstream occlusion time to alarm, and post-occlusion bolos volume.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact CareFusion 303, Inc. or your healthcare provider for instructions. Notification method: Letter
The recall includes Alaris Pump Infusion Sets with reference numbers: C24101E, 10015414, 2447-0007, and others. These products were distributed nationwide in the U.S. and internationally to countries including Canada, the UK, and Australia. Specific model numbers include C24101E and 10015414.
The affected infusion pump modules may perform outside established ranges for flow rate and bolus accuracy. This can lead to incorrect medication delivery, posing serious health risks to patients.
As of the recall date, no specific incidents or injuries were reported. However, the potential for significant harm exists due to inaccurate medication dosing.
Patients and healthcare providers should cease using the recalled infusion sets immediately. Follow the recall instructions provided by the manufacturer and contact CareFusion 303, Inc. for further guidance.
For more information, call CareFusion at 1-800-XXX-XXXX or visit their website at www.carefusion.com.
Get notified about recalls in categories you care about.
Labeling: Incorrect or Missing Lot and/or Exp Date
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
Labeling: Incorrect or Missing Lot and/or Exp Date